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Despite risks of HIV transmission to infants born of the HIV positive women, con-
traceptive use is uncommon among women in HIV discordant partnerships. The 
aim of this study was to determine the factors associated with contraceptive use 
in a clinical trial cohort of HIV serodiscordant couples based in Thika and Eldoret, 
Kenya. Data were analyzed from 481 HIV discordant couples enrolled in the Part-
ners in Prevention HSV/HIV Transmission Study at the Thika and Eldoret sites. 
The primary study outcome was self-reported use of contraception other than 
condoms. Using a marginal longitudinal logistic model based on generalized esti-
mating equations (GEE) approach we assessed the association of various demo-
graphic and behavioral factors with contraceptive use. At baseline the prevalence 
of non barrier contraceptive use among HIV positive and negative women was 
24.3% and 25.7%, respectively. At month 12 of follow-up, the prevalence of 
contraceptive use was 44.4% among the HIV positive and 26% among the HIV 
negative women while at month 24, the prevalence of contraceptive use was 
38.6% among the HIV positive and 18.2% among the HIV negative women. HIV 
positive women were more likely to report using contraception than HIV negative 
women (odds ratio (OR) 1.61 95% confidence interval (CI) 1.04-2.47). Addition-
ally, being married (OR 2.4, 95% CI 1.2-5.0), attending Thika site clinic (OR 6.1, 
95% CI 4.2-9.0), and having two or more children (OR 1.9, 95% CI 1.3-2.8) 
were significantly associated with use of non barrier contraceptives. Future pro-
grams should focus on interventions to increase contraceptive use among HIV 
serodiscordant couples, with a special emphasis on HIV negative women, unmar-
ried women and women with few children. 
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Introduction
In Kenya about 6.1% of 1.3 million 
adults are infected with Human Immun-
odeficiency Virus (HIV) (KAIS., 2008). 
However, the contraceptive prevalence 
rate is low and only 36% of women 
report using modern contraceptive 
methods; there is a 25% unmet need 
for contraception among married 
women (KDHS., 2003). Among mar-
ried individuals in Kenya who are HIV 
infected, 45% have a partner who is 
not currently infected. In addition 10% 
of monogamous married couples and 
14% of polygamous couples are HIV 
serodiscordant (KAIS., 2008). Numer-
ous reports have demonstrated that 
stable HIV discordant couples may be 
responsible for a majority of HIV infec-
tions in Africa (Lingappa et al., 2008; 
Dunkle et al., 2008). 
Contraceptive use is the second pil-
lar of prevention of mother to child 
transmission. This approach involves 
encouraging sexually active women to 
avoid unintended pregnancies by using 
effective methods of contraception. 
Currently, the main approach to pre-
venting mother to child transmission 
has primarily focussed on provision of 
antiretrovirals (ARVs) to mothers and 
their neonates, even though many HIV 
positive births could be prevented by 
preventing unintended pregnancies 
(O’Reilly.,2003;Wilcher et al., 2008; 
Reynolds et al., 2008; Cohen.,2008). 
Among HIV discordant couples, effec-
tive contraceptive use has potential to 
reduce unintended pregnancies and 
consequently reduce HIV exposed 
births. Barrier contraceptive methods 
such as male and female condoms can 
also prevent HIV transmission between 
HIV discordant couples. 
 The limited information regarding 
the factors that influence contraceptive 
use among HIV discordant couples in 
Kenya is a major barrier to developing 
effective programs for HIV prevention. 
Such programs can support positive 
behaviours such as increased contra-
ceptive use and decreased unsafe sex-
ual behaviour. In this study we 
evaluated the correlates of contracep-
tive use among HIV discordant couples 
in a cohort of HIV discordant couples 
participating in an HIV prevention trial 
in Kenya. 
Methods 
Population and procedures: 
This study was conducted as an ancil-
lary study to the Partners in Prevention 
HSV/HIV Transmission Study (Lingappa 
et al., 2009; Celum et al., 2010). Data 
from 481 HIV discordant couples - 341 
in whom the woman was HIV positive 
and 140 in whom the man was HIV 
positive - enrolled at the Thika and 
Eldoret clinical trial sites were analyzed. 
Partipants were followed for a maxi-
mum of 24 months. Enrollment for 
Thika site began June 2006 and Eldoret 
site began in November 2004. Follow 
up for both sites was concluded in 
October 2008. All HIV positive partici-
pants had a CD4>250 cell/ul and were 
not using ARVs at enrollment. All cou-
ples were part of a heterosexual couple 
and had at least 3 sexual contacts in the 
3 months prior to enrollment. During 
follow up HIV positive women visited 
the study clinic monthly while the HIV 
negative women visited the clinic quar-
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terly.
For this analysis, the primary out-
come measure was self-reported use of 
contraception other than condoms. 
This was defined as current use of an 
intra uterine device (IUD), surgical 
methods, injectable, implantable, or 
oral hormonal methods. Contraceptive 
use was compared between HIV posi-
tive and HIV negative women during 
the 24 month follow-up period.
Statistical Analysis
The collected data were cleaned for 
errors and inconsistent answers. To 
describe the characteristics of the study 
participants, the t-test was used to 
compare differences in the means of 
continuous variables and chi-square 
testing was used to compare differ-
ences in categorical factors. To model 
the population-average likelihood of 
contraceptive use a longitudinal logistic 
model for the marginal probability of 
contraceptive use at each time point 
during follow-up was fitted using a gen-
eralized estimating equations (GEE 
approach). The probability of contra-
ceptive use was modelled as a logistic 
function of the covariates thought to be 
predictive of contraceptive use. A cov-
ariate-adjustment for other potentially 
confounding variables was done to 
allow for the analyses of their possible 
role on the association between contra-
ceptive use and predictors of contra-
ceptive use and changes in the 
likelihood of contraceptive use over the 
time. The visit month was modelled as 
a quadratic variable. All the data analy-
ses were done using STATA v.11.0 
(Stata Corp; College Station, TX). We 
used two-sided tests with p-values of 
<0.05 being considered to be statisti-
cally significant.
Ethical considerations: 
This analysis was approved by the 
Kenya Medical Research Institute 
(KEMRI) Ethical and Scientific review 
Committees and the Moi University 
Institutional Research and Ethics Com-
mittee (IREC).
Results
Characteristics of participants
Data from 481 HIV discordant couples 
were analyzed. The HIV positive and 
negative women were statistically simi-
lar with respect to almost all the 
selected baseline characteristics. The 
baseline characteristics of the study 
participants are summarized by their 
HIV status in Table 1.
Contraceptive use 
The baseline prevalence of contracep-
tion was 24.3% for HIV positive 
women (19.8% among the HIV positive 
women in Eldoret and 29.6% among 
HIV positive women in Thika). The 
baseline prevalence was 25.7% for HIV 
negative women (18.6% among HIV 
negative women at Eldoret site and 
37% among HIV negative women in 
Thika site). At each follow-up visit, the 
prevalence of contraceptive use was 
higher among the HIV positive patients 
at each month relative to the HIV nega-
tive group (Figure 1). There was con-
sistent increase in proportion of 
participants using contraception until 
month 18 among the HIV positive 
women when contraceptive use started 
to decline. Among the HIV negative 
women, contraceptive use tends to be 
nearly constant across time and starts 
to decline by month 18 of follow-up. 
Notably, most participants were exited 
the Partners in Prevention study before 
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completing their 24 months of follow 
up as a result of the study coming to an 
end. 
The proportion of participants using 
various forms of non-condom contra-
ceptives at any given month during fol-
low-up is shown in Table 2. We 
observed that at any follow-up month, 
injectable methods were the most 
common, while almost over 60% of 
participants were not using any form of 
contraception. 
Reported condom use was high 
through out the follow up period for 
sex with study and non study partners. 
This rose from 75.47% at baseline to 
94.02% at month 24 of follow up for 
Table 1 Baseline Characteristics of HIV-1 positive and negative women
 N HIV- HIV+
Site
      Eldoret 268 86(61.4) 182(53.4)
      Thika 213 54(38.6) 159(46.6)
Age
      <=24 102 26(18.6) 76(22.3)
      25-34 256 67(47.9) 189(55.4)
      35-44 99 38(27.1) 61(17.9)
      >=45 24 9(6.4) 14(4.4)
Married to study partner 453 134(95.7) 319(93.5)
Number of children
      0 50 10(7.1) 40(11.7)
      1 85 21(15) 64(18.8)
      >=2 346 109(77.9) 237(69.5)
Contraception
      None 362 104(74.3) 258(75.7)
      Oral 16 5(3.6) 11(3.2)
      IUD 7 4(2.9) 3(0.9)
      Injectables 71 21(15) 50(14.7)
      Implant 5 1(0.7) 4(1.2)
      Hysterectomy 20 5(3.6) 15(4.4)
Pregnant during follow up
      No 364 99(70.7) 265(77.7)
      Yes 117 41(29.3) 76(22.3)
Baseline CD4 count for HIV+  Female
250-349 66(19.4)
350-499 104(30.5)
>500 171(50.1)
Baseline CD4 count for HIV+   Male
250-349 42(30)
350-499 50(35.7)
>500 48(34.3)
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sex with study partners and remained 
>95% through out follow up for sex 
with other partners.
Correlates of contraceptive use
The odds of contraceptive use were 
1.61 (95% CI: (1.04-2.47) times as 
likely among the HIV positive women 
than in those who were HIV negative 
(Table 3). From the model further sta-
tistically significant correlates of non 
barrier contraceptive use were being 
married (OR=2.4, 95% CI 1.2-5.0), 
coming from Thika site (OR = 6.1, 
95%CI 4.2-9.0) and having two or 
more children (OR = 1.9, 95% CI 1.3-
Table 2 Contraceptive methods used during study visit months as among HIV positive 
and HIV negative women
 Follow-up Month
Contraception 0 3 6 9 12 15 18 21 24 Total
 N                         481 463 450      427 397 348 263 156 111
None 75.26 75.50 70.07 65.24 63.01 59.02 59.31 65.13 67.39 67.13
Oral 3.33 1.99 2.49 3.81 5.25 6.34 6.30 5.46 4.35 4.21
IUD 1.46 1.10 1.13 0.95 0.72 0.98 0.86 1.68 0.54 1.06
Injectables 14.76 15.23 18.59 21.67 21.00 22.44 22.06 19.75 21.74 19.35
Implant 1.04 1.55 2.27 2.86 3.82 4.88 5.44 4.20 2.72 3.06
Hysterectomy 4.16 4.64 5.44 5.48 6.21 6.34 6.02 3.78 3.26 5.18
Table 3 Marginal logistic regression analysis of baseline HIV status and longitudinal 
contraceptive use using generalized estimating equations
Covariate N OR p 95%CI
HIV status at enrolment  
Negative* 801 1               
Positive 2294 1.605 0.032 (1.042-2.472)
Visit month 3095 0.997 <0.001 (0.996-0.999)
Married to study partner  
No* 181 1               
Yes 2914 2.431 0.015 (1.188-4.976)
Age 3095 0.949 <0.001 (0.922-0.977)
Site  
Eldoret* 1696 1               
Thika 1399 6.116 <0.001 (4.156-9.002)
Pregnant during follow up  
No* 2421 1               
Yes 674 0.888 0.591 (0.576-1.369)
Number of Children  
1* 809 1               
>=2 2286 1.868 0.003 (1.245-2.804)
* Baseline category
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2.8). Being on ARVs and the CD4 count 
of the HIV positive partner were not 
significantly associated with contracep-
tive use. Also not associated with con-
traceptive use was whether or not both 
male partner used condoms, whether 
or not both male and female earned 
income, whether or not male or female 
has been abused, years of education for 
both male and female and female being 
pregnant during follow-up (data not 
shown).
Discussion
This prospective study evaluated the 
correlates of contraceptive use among 
HIV discordant couples in an HIV pre-
vention trial setting in Kenya. HIV posi-
tive women were more likely to report 
contraceptive use during follow up vis-
its than HIV negative women. This 
result is similar to other studies con-
ducted in resources poor countries that 
have found that HIV status may strongly 
influence contraceptive use, with HIV 
positive women reporting a significantly 
higher use (Batya et al., 2009; Hoffman 
et al., 2008; Keogh et al., 2009). How-
ever, this finding contrasts the (KAIS., 
2007), which reported higher contra-
ceptive use among HIV negative 
women compared to the HIV positive 
women. One possible explanation is 
HIV positive women in our cohort 
attended the clinic on monthly basis and 
thus received more contraceptive 
counselling compared to HIV negative 
women who attended the clinic on a 
quarterly basis. 
We observed that being married 
was significantly associated with an 
increased likelihood of using contracep-
tives. Similar findings were reported 
among HIV positive women receiving 
prevention of mother to child transmis-
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sion (PMTCT) services in Rwanda and 
Cote d’Ivoire where women in a union 
were more likely to report a modern 
method (Batya et al., 2009;Desgrees et 
al., 2002). 
In this analysis, having more chil-
dren was significantly associated with 
increased likelihood of using contracep-
tives. This has been reported in a study 
among HIV positive and negative 
PMTCT clients in a South Africa where 
having fewer children was associated 
with greater pregnancy desire among 
the HIV negative women (Peltzer et al., 
2009). Additionally, a study among HIV 
positive and negative women in the 
national PMTCT program in Rwanda 
found women with fewer children had 
a stronger desire for additional children 
(Hoffman et al., 2008).
Thika site had a significantly higher 
contraceptive use than Eldoret site per-
haps due to the successful multi-
pronged family planning strategy that 
was invoked at the Thika site and not in 
Eldoret. This strategy involved training 
of counselors and clinicians and provi-
sion of non-barrier contraceptive meth-
ods free of charge at the research clinic 
(Ngure et al., 2009).
Over half of the contraceptive users 
chose injectables compared to other 
forms of contraceptives at each time- 
point. This reflects the pattern in many 
African countries where the Injectable 
contraceptive depot-medroxyproges-
terone acetate (DMPA) is a popular 
option among women, due to among 
other reasons ease of use and the 
opportunity for discreet use (Lavreys et 
al., 2004). 
The strengths of our study include 
its design as a prospective cohort study 
and its ability to observe contraceptive 
use over time and up-to 24 months of 
follow-up for each couple. As both 
members of the couple were enrolled 
in the study, we were able to assess 
contraceptive use among HIV positive 
and HIV negative women and include 
data on male HIV positive partners to 
accompany data on the behaviors of 
HIV negative women. A lack of infor-
mation on male partners has been a 
limitation in many contraceptive studies 
(Wilson et al., 2003). Our study is a 
sub-analysis within the larger prospec-
tive study of contraceptive use among 
over 3400 African women in HIV-1 
serodiscordant partnerships (Heffron et 
al., 2010). We focused our sub-analysis 
specifically on contraceptive use in 2 
different geographical regions in Kenya 
and this enabled us to evaluate the 
effect of multiple and additional varia-
bles on contraceptive use. 
Our study had a number of limita-
tions. First this study was carried out in 
the context of a clinical trial setting, 
where contraception was mainly pro-
vided free of charge at one of the study 
clinics (Thika). This may reduce the 
generalizability of the findings to the 
general Kenyan population. Secondly, 
our study relied on self reported con-
traceptive use and we did not validate 
its accuracy. Thirdly, we did not assess 
pregnancy intention and fertility desires 
in this study and this limits our ability to 
interpret the results. Lastly Thika and 
Eldoret sites were among the last sites 
to be activated in the Partners in Pre-
vention trial, therefore by the time the 
study came to an end most of the par-
ticipants had not completed their 24 
month follow-up, perhaps a more con-
sistent trend would have been 
observed with a longer follow-up.
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In conclusion, promoting dual con-
traceptive use among HIV discordant 
couples is of critical importance. Future 
programs should focus on interventions 
to increase non-barrier contraceptive 
use among women in serodiscordant 
relationships, with a special emphasis 
on single women with few children and 
their male partners using a multi-
pronged pronged strategy (Ngure et al., 
2009).
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